Author: Cunha, Marcela Juliano Silva; Pinto, Carlos Augusto Ventura; Guerra, João Carlos de Campos; Tachibana, Adriano; Portugal, Maria Fernanda Cassino; Ferraz, Leonardo José Rolim; Wolosker, Nelson
Title: Incidence, diagnosis, treatment methods, and outcomes of clinically suspected venous thromboembolic disease in patients with COVID-19 in a quaternary hospital in Brazil Cord-id: i36mbtu5 Document date: 2021_6_11
ID: i36mbtu5
Snippet: BACKGROUND: Prothrombotic states have been associated with viral infections and the novel Sars-COV-2 infection has been associated with elevated D-dimer levels, although no causal relation has been clearly established. OBJECTIVES: This study presents an epidemiological analysis of manifest VTE episodes in a group of patients hospitalized because of COVID-19. METHODS: Medical records of patients who presented symptomatic deep vein thrombosis and/or pulmonary embolism in concomitance with confirme
Document: BACKGROUND: Prothrombotic states have been associated with viral infections and the novel Sars-COV-2 infection has been associated with elevated D-dimer levels, although no causal relation has been clearly established. OBJECTIVES: This study presents an epidemiological analysis of manifest VTE episodes in a group of patients hospitalized because of COVID-19. METHODS: Medical records of patients who presented symptomatic deep vein thrombosis and/or pulmonary embolism in concomitance with confirmed COVID-19 were retrospectively studied. Demographic characteristics, prevalence of VTE, site of occurrence, D-dimer variation over time, management, and outcomes were analyzed. RESULTS: During the study period, 484 confirmed cases of COVID-19 were admitted, 64 of which displayed VTE symptoms and 13 of which had confirmed symptomatic VTE(2.68% of total sample and 20.31% of symptomatic cases). Most cases (76.92%) occurred in intensive care. On the day attributed to VTE onset, D-dimer levels were over 3,000 ng/mL in 8 (80%) patients, a significant increase from baseline admission levels (p < 0.05). A significant decrease was also observed in D-dimer values at hospital discharge (p < 0.05). All patients received pharmacological thromboprophylaxis and/or anticoagulation as indicated. Two deaths occurred during the study, both patients with severe comorbidities. At the end of our study protocol, nine patients had been discharged and two remained hospitalized, but had no signs of VTE worsening. CONCLUSIONS: VTE prevalence in hospitalized COVID-19 patients was 2.7%, and higher in intensive care units. Early institution of prophylaxis and immediate full anticoagulation when VTE is diagnosed should be the goals of those who treat this kind of patient.
Search related documents:
Co phrase search for related documents- acute renal failure and admission start: 1
- acute renal failure and lmwh weight heparin: 1
- acute renal failure and low molecular: 1, 2, 3
- acute renal failure and low molecular lmwh weight heparin: 1
- acute renal failure and low probability: 1
- acute renal failure and low threshold: 1
- adequate despite and low molecular: 1, 2
- admission dvt and lmwh weight heparin: 1
- admission dvt and low molecular: 1
- admission dvt and low molecular lmwh weight heparin: 1
- admission level and lmwh weight heparin: 1
- admission level and low molecular: 1, 2
- admission level and low molecular lmwh weight heparin: 1
- admission level and low threshold: 1
- lmwh weight heparin and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- lmwh weight heparin and low probability: 1
Co phrase search for related documents, hyperlinks ordered by date